Patents by Inventor Keisuke Imamura

Keisuke Imamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fused heterocyclic compound
    Patent number: 10577382
    Abstract: Provided is a compound represented by the following formula, or a salt thereof: [wherein each symbol is as defined herein].
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: March 3, 2020
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Youichi Kawakita, Takuto Kojima, Noriyuki Nii, Yoshiteru Ito, Nobuki Sakauchi, Hiroshi Banno, Xin Liu, Koji Ono, Keisuke Imamura, Shinichi Imamura
  • SAFETY SHUTDOWN CONTROL OF VIRTUAL MACHINES RUNNING ON A HOST APPARATUS
    Publication number: 20200065143
    Abstract: An apparatus sets a priority for each of a plurality of virtual machines such that a higher priority is given for a virtual machine having a lower processing load, and sets a precedence order of Input/Output (I/O) processing based on the priority in a case where a power supply of the information processing apparatus is switched to an uninterruptible power supply, where the priority is based on processing loads of the plurality of virtual machines immediately before the power supply of the information processing apparatus is switched to the uninterruptible power supply, and the I/O processing indicates at least one of writing from each of the plurality of virtual machines to the memory and reading from the memory to the virtual machine. The apparatus performs, for each of the plurality of virtual machines, the I/O processing from the virtual machine to the memory in accordance with the precedence order.
    Type: Application
    Filed: July 29, 2019
    Publication date: February 27, 2020
    Applicant: FUJITSU LIMITED
    Inventor: Keisuke Imamura
  • HETEROCYCLIC COMPOUND AND USE THEREOF
    Publication number: 20200017444
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 16, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi KAJITA, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Norio OYABU, Masaki OGINO, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Heterocyclic compound and use thereof
    Patent number: 10428023
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: October 1, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike, Kohei Takeuchi, Yoshiteru Ito, Norihito Tokunaga, Takahiro Sugimoto, Tohru Miyazaki, Tsuneo Oda, Yasutaka Hoashi, Yasushi Hattori, Keisuke Imamura
  • FUSED HETEROCYCLIC COMPOUND
    Publication number: 20190106437
    Abstract: Provided is a compound represented by the following formula, or a salt thereof: [wherein each symbol is as defined herein.].
    Type: Application
    Filed: April 27, 2017
    Publication date: April 11, 2019
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Youichi KAWAKITA, Takuto KOJIMA, Noriyuki NII, Yoshiteru ITO, Nobuki SAKAUCHI, Hiroshi BANNO, Xin LIU, Koji ONO, Keisuke IMAMURA, Shinichi IMAMURA
  • HETEROCYCLIC COMPOUND AND USE THEREOF
    Publication number: 20190040010
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: August 2, 2018
    Publication date: February 7, 2019
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi Kajita, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Norio OHYABU, Masaki OGINO, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • COMPUTER-READABLE RECORDING MEDIUM HAVING STORED THEREIN PROGRAM, INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING SYSTEM, AND METHOD FOR PROCESSING INFORMATION
    Publication number: 20170329644
    Abstract: An information processing apparatus includes a processor configured to: cause a plurality of processor cores (threads) to execute processes (packet processes) of a plurality of virtual functions (VNFs) each including one or more virtual interfaces (VNICs); and allocate the plurality of virtual functions to the plurality of processor cores in a unit of each of the plurality of virtual functions such that the one or more of the virtual interfaces included in each of the plurality of virtual functions belong to one of the plurality of processor cores. This enable to ensure processing capability in a unit of a virtual function.
    Type: Application
    Filed: April 14, 2017
    Publication date: November 16, 2017
    Applicant: FUJITSU LIMITED
    Inventor: Keisuke Imamura
  • PYRIDAZINE COMPOUND
    Publication number: 20170015654
    Abstract: The present provides a pyridazine compound having an inhibiting effect on Stearoyl-CoA desaturase (SCD) (in particular, SCD1). The present provides a compound represented by formula (where each symbol is as defined as in the Specification) or a salt thereof.
    Type: Application
    Filed: March 11, 2015
    Publication date: January 19, 2017
    Inventors: Keisuke IMAMURA, Naoki TOMITA, Yoshiteru ITO, Koji ONO, Hironobu MAEZAKI, Noriyuki NII
  • Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
    Patent number: 9226921
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: January 5, 2016
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Takahiko Taniguchi, Masato Yoshikawa, Kasei Miura, Tomoaki Hasui, Eiji Honda, Keisuke Imamura, Makoto Kamata, John F. Quinn, Joseph Raker, Fatoumata Camara, Yi Wang
  • Condensed heterocyclic compound
    Patent number: 9029388
    Abstract: The present invention provides a compound having a superior PDE10A inhibitory action and use thereof. The compound is a compound represented by the following formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: May 12, 2015
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Takahiko Taniguchi, Jun Kunitomo, Masato Yoshikawa, Tomoaki Hasui, Eiji Honda, Keisuke Imamura, Haruhi Kamisaki, Shinkichi Suzuki, Kasei Miura
  • Fused heterocyclic compounds
    Patent number: 8940758
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I): wherein the symbols are defined in the specification.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: January 27, 2015
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Takahiko Taniguchi, Masato Yoshikawa, Kasei Miura, Tomoaki Hasui, Eiji Honda, Keisuke Imamura, Makoto Kamata, Haruhi Ando
  • Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors
    Patent number: 8846713
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: September 30, 2014
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Takahiko Taniguchi, Masato Yoshikawa, Kasei Miura, Tomoaki Hasui, Eiji Honda, Keisuke Imamura, Makoto Kamata
  • FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS
    Publication number: 20140228320
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):
    Type: Application
    Filed: April 15, 2014
    Publication date: August 14, 2014
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Takahiko TANIGUCHI, Masato YOSHIKAWA, Kasei MIURA, Tomoaki HASUI, Eiji HONDA, Keisuke IMAMURA, Makoto KAMATA, Haruhi KAMISAKI, John F. QUINN, Joseph RAKER, Fatoumata CAMARA, Yi WANG
  • Pressure adjustor and method of manufacturing the same, speaker device using the pressure adjustor, electronic device, and vehicle
    Patent number: 8767998
    Abstract: A pressure adjustor includes a sheet-like supporter formed of unwoven fabric or woven fabric, a plurality of activated carbon powder particles attached to the supporter, and binders binding the plurality of activated carbon powder particles to each other. If this pressure adjustor is disposed inside a cabinet of a speaker device including a speaker unit provided in the cabinet, a speaker device is obtained which has an excellent bass reproduction effect even if the device is made small.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: July 1, 2014
    Assignee: Panasonic Corporation
    Inventors: Keisuke Imamura, Yukihiro Shimasaki, Kiyoshi Ohashi, Yoshimichi Kajihara, Yohei Jin
  • Capacitor having a characterized electrode and method for manufacturing same
    Patent number: 8705226
    Abstract: A capacitor includes a film previously provided on both sides or one side of a collector by anodizing or the like, further a conductive layer provided on the film, and a polarizable electrode layer as an electrode portion on the conductive layer. Thus, the capacitor suppresses the reaction between a driving electrolyte and the collector after a long time of use because the reactivity between the film previously provided on both sides or one side of the collector and the driving electrolyte is low. Furthermore, since the conductive layer is provided, it is possible to reduce an initial contact resistance on the surface of the collector, and to enhance an effect of suppressing performance deterioration by the film.
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: April 22, 2014
    Assignee: Panasonic Corporation
    Inventors: Keisuke Imamura, Kouichi Kojima
  • CONDENSED HETEROCYCLIC COMPOUND
    Publication number: 20130331409
    Abstract: The present invention provides a compound having a superior PDE10A inhibitory action and use thereof. The compound is a compound represented by the following formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.
    Type: Application
    Filed: March 15, 2012
    Publication date: December 12, 2013
    Inventors: Takahiko Taniguchi, Jun Kunitomo, Masato Yoshikawa, Tomoaki Hasui, Eiji Honda, Keisuke Imamura, Haruhi Kamisaki, Shinkichi Suzuki, Kasei Miura
  • FUSED HETEROCYCLIC COMPOUNDS
    Publication number: 20130303553
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I): wherein the symbols are defined in the specification.
    Type: Application
    Filed: July 17, 2013
    Publication date: November 14, 2013
    Inventors: Takahiko TANIGUCHI, Masato YOSHIKAWA, Kasei MIURA, Tomoaki HASUI, Eiji HONDA, Keisuke IMAMURA, Makoto KAMATA, Haruhi KAMISAKI
  • Fused heterocyclic compounds
    Patent number: 8563575
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I): wherein the symbols are defined in the specification.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: October 22, 2013
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Takahiko Taniguchi, Masato Yoshikawa, Kasei Miura, Tomoaki Hasui, Eiji Honda, Keisuke Imamura, Makoto Kamata, Haruhi Kamisaki
  • FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS
    Publication number: 20130172328
    Abstract: The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):
    Type: Application
    Filed: June 22, 2011
    Publication date: July 4, 2013
    Applicant: CROSSWING INC.
    Inventors: Takahiko Taniguchi, Masato Yoshikawa, Kasei Miura, Tomoaki Hasui, Eiji Honda, Keisuke Imamura, Makoto Kamata, Haruhi Kamisaki, John F. Quinn, Joseph Raker, Fatoumata Camara, Yi Wang
  • Light-emitting diode lamp
    Patent number: D661416
    Type: Grant
    Filed: September 12, 2011
    Date of Patent: June 5, 2012
    Assignee: Panasonic Corporation
    Inventors: Nobuyuki Mase, Yoshitaka Kurimoto, Katsushi Seki, Keisuke Imamura, Yosuke Fujimaki, Masashi Sakata, Nozomu Hashimoto, Masato Matsumoto